Tel Aviv University scientists have devised a novel biosensor that can isolate and target all leukemic stem cells – the most malignant of leukemic cells. Previous therapies missed many types of these stem cells, allowing them to evade destruction and subsequently multiply.
No escape from new leukemia biosensor
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.